UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis

Annals of oncology, 2021-08, Vol.32 (8), p.983-993

2021

Volltextzugriff (PDF)

Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer

Annals of oncology, 2020-05, Vol.31 (5), p.582-589

2020

Volltextzugriff (PDF)

Adventure-based training to promote physical activity and reduce fatigue among childhood cancer survivors: A randomized controlled trial

International journal of nursing studies, 2018-07, Vol.83, p.65-74

2018

Volltextzugriff (PDF)

296P Tumour mutational burden and clinical outcomes with first-line atezolizumab and nab-paclitaxel in triple-negative breast cancer: Exploratory analysis of the phase III IMpassion130 trial

Annals of oncology, 2020-09, Vol.31, p.S360-S361

2020

Volltextzugriff (PDF)

Corrigendum to ‘First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis’

Annals of oncology, 2021-12, Vol.32 (12), p.1650

2021

Volltextzugriff (PDF)

Corrigendum to ‘First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis’

Annals of oncology, 2021-10, Vol.32 (10), p.1308

2021

Volltextzugriff (PDF)

Association of systemic corticosteroids with overall survival in patients receiving cancer immunotherapy for advanced melanoma, non-small cell lung cancer or urothelial cancer in routine clinical practice

Annals of oncology, 2019-12, Vol.30, p.xi16-xi17

2019

Volltextzugriff (PDF)

Corrigendum to ‘First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis’: Annals of Oncology 2021; 32: 983-993

Annals of oncology, 2021-12, Vol.32 (12), p.1650-1650

2021

Volltextzugriff (PDF)

Corrigendum to ‘First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis’: Annals of Oncology 2021; volume 32: 983–993

Annals of oncology, 2021-10, Vol.32 (10), p.1308-1308

2021

Volltextzugriff (PDF)

LBA16 IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer

Annals of oncology, 2020-09, Vol.31, p.S1148-S1148

2020

Volltextzugriff (PDF)

Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130

Annals of oncology, 2019-10, Vol.30, p.v858-v859

2019

Volltextzugriff (PDF)

LBA20 - Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130

Annals of oncology, 2019-10, Vol.30, p.v858-v859

2019

Volltextzugriff (PDF)

IMpassion130: Results from a global, randomised, double-blind, phase III study of atezolizumab (atezo) + nab-paclitaxel (nab-P) vs placebo + nab-P in treatment-naive, locally advanced or metastatic triple-negative breast cancer (mTNBC)

Annals of oncology, 2018-10, Vol.29, p.viii707-viii708

2018

Volltextzugriff (PDF)

LBA11 IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemotherapy in early triple-negative breast cancer (TNBC)

Annals of oncology, 2020-09, Vol.31, p.S1144-S1144

2020

Volltextzugriff (PDF)

Subgroup analysis of IMpassion130: Atezolizumab + nab-paclitaxel (nab-P) in patients (pts) with advanced triple-negative breast cancer (TNBC) in Asian countries

Annals of oncology, 2019-11, Vol.30, p.ix13-ix14

2019

Volltextzugriff (PDF)

136TiP IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC

Annals of oncology, 2016-12, Vol.27, p.ix40-ix40

2016

Volltextzugriff (PDF)

136TiP IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

LBA1 Final analysis of the placebo-controlled randomised phase III IMpassion031 trial evaluating neoadjuvant atezolizumab (atezo) plus chemotherapy (CT) followed by open-label adjuvant atezo in patients (pts) with early-stage triple-negative breast cancer (eTNBC)

ESMO open, 2023-05, Vol.8 (1), p.101571, Article 101571

2023

Volltextzugriff (PDF)

A chemically functionalizable nanoporous material

Science (American Association for the Advancement of Science), 1999-02, Vol.283 (5405), p.1148-1150

1999

Volltextzugriff (PDF)

Allogeneic Lymphocytes Induce Tumor Regression of Advanced Metastatic Breast Cancer

Breast diseases, 2005-07, Vol.16 (2), p.184

Chui, S.Y.

2005

Volltextzugriff (PDF)

Microporous chiral metal coordination polymers: hydrothermal synthesis, channel engineering and stability of lanthanide tartrates

Chemical communications (Cambridge, England), 2005-11 (44), p.5515-5517

2005

Volltextzugriff (PDF)

Cooperative magnetic behavior in the coordination polymers [Cu3(TMA)2L3] (L=H2O, pyridine)

Journal of applied physics, 2000-05, Vol.87 (9), p.6007-6009

2000

Volltextzugriff (PDF)

Physical stability vs. chemical lability in microporous metal coordination polymers: a comparison of [Cu(OH)(INA)]n and [Cu(INA)2]n: INA = 1,4-(NC5H4CO2)

Chemical communications (Cambridge, England), 2002-08 (15), p.1642-1643

2002

Volltextzugriff (PDF)

Leveraging LMS Logs to Analyze Self-Regulated Learning Behaviors in a Maker-based Course

LAK23: 13th International Learning Analytics and Knowledge Conference, 2023, p.670-676

2023

Volltextzugriff (PDF)

Hydrothermal synthesis of indium tartrates: Structures of the chiral polymer [In(l-TAR)3−H2O]·0.5H2O containing the tartrate trianion, and a microporous hybrid solid [In(OH)(d/l-TAR)2−]·2H2O

Inorganic chemistry communications, 2006-05, Vol.9 (5), p.507-511

2006

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis

Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer

Adventure-based training to promote physical activity and reduce fatigue among childhood cancer survivors: A randomized controlled trial

296P Tumour mutational burden and clinical outcomes with first-line atezolizumab and nab-paclitaxel in triple-negative breast cancer: Exploratory analysis of the phase III IMpassion130 trial

Corrigendum to ‘First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis’

Corrigendum to ‘First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis’

Association of systemic corticosteroids with overall survival in patients receiving cancer immunotherapy for advanced melanoma, non-small cell lung cancer or urothelial cancer in routine clinical practice

Corrigendum to ‘First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis’: Annals of Oncology 2021; 32: 983-993

Corrigendum to ‘First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis’: Annals of Oncology 2021; volume 32: 983–993

LBA16 IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer

Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130

LBA20 - Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130

IMpassion130: Results from a global, randomised, double-blind, phase III study of atezolizumab (atezo) + nab-paclitaxel (nab-P) vs placebo + nab-P in treatment-naive, locally advanced or metastatic triple-negative breast cancer (mTNBC)

LBA11 IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemotherapy in early triple-negative breast cancer (TNBC)

Subgroup analysis of IMpassion130: Atezolizumab + nab-paclitaxel (nab-P) in patients (pts) with advanced triple-negative breast cancer (TNBC) in Asian countries

136TiP IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC

136TiP IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC

LBA1 Final analysis of the placebo-controlled randomised phase III IMpassion031 trial evaluating neoadjuvant atezolizumab (atezo) plus chemotherapy (CT) followed by open-label adjuvant atezo in patients (pts) with early-stage triple-negative breast cancer (eTNBC)

A chemically functionalizable nanoporous material

Allogeneic Lymphocytes Induce Tumor Regression of Advanced Metastatic Breast Cancer

Microporous chiral metal coordination polymers: hydrothermal synthesis, channel engineering and stability of lanthanide tartrates

Cooperative magnetic behavior in the coordination polymers [Cu3(TMA)2L3] (L=H2O, pyridine)

Physical stability vs. chemical lability in microporous metal coordination polymers: a comparison of [Cu(OH)(INA)]n and [Cu(INA)2]n: INA = 1,4-(NC5H4CO2)

Leveraging LMS Logs to Analyze Self-Regulated Learning Behaviors in a Maker-based Course

Hydrothermal synthesis of indium tartrates: Structures of the chiral polymer [In(l-TAR)3−H2O]·0.5H2O containing the tartrate trianion, and a microporous hybrid solid [In(OH)(d/l-TAR)2−]·2H2O

Suchergebnisse filtern